KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Arbutus Biopharma (ABUS) Shares Outstanding (Diluted Average) (2016 - 2025)

Arbutus Biopharma (ABUS) has disclosed Shares Outstanding (Diluted Average) for 15 consecutive years, with $191.6 million as the latest value for Q4 2025.

  • Quarterly Shares Outstanding (Diluted Average) rose 3.23% to $191.6 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $191.6 million through Dec 2025, up 3.23% year-over-year, with the annual reading at $191.6 million for FY2025, 3.23% up from the prior year.
  • Shares Outstanding (Diluted Average) hit $191.6 million in Q4 2025 for Arbutus Biopharma, roughly flat from $191.3 million in the prior quarter.
  • In the past five years, Shares Outstanding (Diluted Average) ranged from a high of $192.4 million in Q2 2025 to a low of $93.4 million in Q1 2021.
  • Historically, Shares Outstanding (Diluted Average) has averaged $157.6 million across 5 years, with a median of $166.0 million in 2023.
  • Biggest five-year swings in Shares Outstanding (Diluted Average): surged 58.86% in 2022 and later grew 2.32% in 2025.
  • Year by year, Shares Outstanding (Diluted Average) stood at $106.2 million in 2021, then surged by 42.07% to $150.9 million in 2022, then grew by 9.95% to $166.0 million in 2023, then increased by 11.84% to $185.6 million in 2024, then rose by 3.23% to $191.6 million in 2025.
  • Business Quant data shows Shares Outstanding (Diluted Average) for ABUS at $191.6 million in Q4 2025, $191.3 million in Q3 2025, and $192.4 million in Q2 2025.